{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:48:06Z","timestamp":1783032486224,"version":"3.54.6"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Skeletal Muscle"],"DOI":"10.1186\/s13395-024-00361-3","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T10:24:25Z","timestamp":1733221465000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["SIX transcription factors are necessary for the activation of DUX4 expression in facioscapulohumeral muscular dystrophy"],"prefix":"10.1186","volume":"14","author":[{"given":"Amelia","family":"Fox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajanikanth","family":"Vangipurapu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis M.","family":"Sverdrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,3]]},"reference":[{"issue":"R2","key":"361_CR1","doi-asserted-by":"publisher","first-page":"R153","DOI":"10.1093\/hmg\/ddy162","volume":"27","author":"AE Campbell","year":"2018","unstructured":"Campbell AE, et al. Facioscapulohumeral dystrophy: activating an early embryonic transcriptional program in human skeletal muscle. Hum Mol Genet. 2018;27(R2):R153\u201362.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"361_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/mus.20522","volume":"34","author":"R Tawil","year":"2006","unstructured":"Tawil R, van der Maarel SM. Facioscapulohumeral muscular dystrophy. Muscle Nerve. 2006;34(1):1\u201315.","journal-title":"Muscle Nerve"},{"key":"361_CR3","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1146\/annurev-genom-083118-014933","volume":"20","author":"CL Himeda","year":"2019","unstructured":"Himeda CL, Jones PL. The Genetics and Epigenetics of Facioscapulohumeral Muscular Dystrophy. Annu Rev Genomics Hum Genet. 2019;20:265\u201391.","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"4","key":"361_CR4","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1001\/archneur.1994.00540160085011","volume":"51","author":"OF Brouwer","year":"1994","unstructured":"Brouwer OF, et al. Facioscapulohumeral muscular dystrophy in early childhood. Arch Neurol. 1994;51(4):387\u201394.","journal-title":"Arch Neurol"},{"issue":"5","key":"361_CR5","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/ana.25326","volume":"84","author":"RJM Goselink","year":"2018","unstructured":"Goselink RJM, et al. Facioscapulohumeral Dystrophy in Childhood: A Nationwide Natural History Study. Ann Neurol. 2018;84(5):627\u201337.","journal-title":"Ann Neurol"},{"key":"361_CR6","doi-asserted-by":"crossref","unstructured":"Statland JM, Tawil R. Facioscapulohumeral Muscular Dystrophy. Continuum (Minneap Minn). 2016;22(6, Muscle and Neuromuscular Junction Disorders):1916\u20131931.","DOI":"10.1212\/CON.0000000000000399"},{"key":"361_CR7","doi-asserted-by":"crossref","unstructured":"Statland J, Tawil R, Facioscapulohumeral muscular dystrophy. Neurol Clin. 2014;32(3):721\u20138, ix.","DOI":"10.1016\/j.ncl.2014.04.003"},{"issue":"5999","key":"361_CR8","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1126\/science.1189044","volume":"329","author":"RJ Lemmers","year":"2010","unstructured":"Lemmers RJ, et al. A unifying genetic model for facioscapulohumeral muscular dystrophy. Science. 2010;329(5999):1650\u20133.","journal-title":"Science"},{"key":"361_CR9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/2044-5040-4-12","volume":"4","author":"R Tawil","year":"2014","unstructured":"Tawil R, van der Maarel SM, Tapscott SJ. Facioscapulohumeral dystrophy: the path to consensus on pathophysiology. Skelet Muscle. 2014;4:12.","journal-title":"Skelet Muscle"},{"issue":"5","key":"361_CR10","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1097\/WCO.0b013e328357f22d","volume":"25","author":"SM van der Maarel","year":"2012","unstructured":"van der Maarel SM, et al. Facioscapulohumeral muscular dystrophy: consequences of chromatin relaxation. Curr Opin Neurol. 2012;25(5):614\u201320.","journal-title":"Curr Opin Neurol"},{"issue":"8716","key":"361_CR11","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/0140-6736(90)92148-B","volume":"336","author":"C Wijmenga","year":"1990","unstructured":"Wijmenga C, et al. Location of facioscapulohumeral muscular dystrophy gene on chromosome 4. Lancet. 1990;336(8716):651\u20133.","journal-title":"Lancet"},{"issue":"23","key":"361_CR12","doi-asserted-by":"publisher","first-page":"e2441","DOI":"10.1212\/WNL.0000000000009617","volume":"94","author":"K Hamanaka","year":"2020","unstructured":"Hamanaka K, et al. Homozygous nonsense variant in LRIF1 associated with facioscapulohumeral muscular dystrophy. Neurology. 2020;94(23):e2441\u20137.","journal-title":"Neurology"},{"issue":"12","key":"361_CR13","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1080\/15592294.2015.1113798","volume":"10","author":"J Balog","year":"2015","unstructured":"Balog J, et al. Increased DUX4 expression during muscle differentiation correlates with decreased SMCHD1 protein levels at D4Z4. Epigenetics. 2015;10(12):1133\u201342.","journal-title":"Epigenetics"},{"key":"361_CR14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.gde.2015.08.007","volume":"33","author":"L Daxinger","year":"2015","unstructured":"Daxinger L, Tapscott SJ, van der Maarel SM. Genetic and epigenetic contributors to FSHD. Curr Opin Genet Dev. 2015;33:56\u201361.","journal-title":"Curr Opin Genet Dev"},{"issue":"4","key":"361_CR15","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/ng1262","volume":"35","author":"PG van Overveld","year":"2003","unstructured":"van Overveld PG, et al. Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy. Nat Genet. 2003;35(4):315\u20137.","journal-title":"Nat Genet"},{"key":"361_CR16","doi-asserted-by":"crossref","unstructured":"Mocciaro E, et al. DUX4 Role in Normal Physiology and in FSHD Muscular Dystrophy. Cells. 2021;10(12):3322.","DOI":"10.3390\/cells10123322"},{"issue":"1","key":"361_CR17","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41564-018-0285-5","volume":"4","author":"F Full","year":"2019","unstructured":"Full F, et al. Centrosomal protein TRIM43 restricts herpesvirus infection by regulating nuclear lamina integrity. Nat Microbiol. 2019;4(1):164\u201376.","journal-title":"Nat Microbiol"},{"key":"361_CR18","doi-asserted-by":"publisher","first-page":"11790","DOI":"10.1038\/ncomms11790","volume":"7","author":"H Lilljebjorn","year":"2016","unstructured":"Lilljebjorn H, et al. Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia. Nat Commun. 2016;7:11790.","journal-title":"Nat Commun"},{"issue":"9","key":"361_CR19","doi-asserted-by":"publisher","first-page":"113114","DOI":"10.1016\/j.celrep.2023.113114","volume":"42","author":"AA Smith","year":"2023","unstructured":"Smith AA, et al. DUX4 expression in cancer induces a metastable early embryonic totipotent program. Cell Rep. 2023;42(9):113114.","journal-title":"Cell Rep"},{"issue":"6","key":"361_CR20","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/ng.3858","volume":"49","author":"A De Iaco","year":"2017","unstructured":"De Iaco A, et al. DUX-family transcription factors regulate zygotic genome activation in placental mammals. Nat Genet. 2017;49(6):941\u20135.","journal-title":"Nat Genet"},{"issue":"10","key":"361_CR21","doi-asserted-by":"publisher","first-page":"e1001181","DOI":"10.1371\/journal.pgen.1001181","volume":"6","author":"L Snider","year":"2010","unstructured":"Snider L, et al. Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene. PLoS Genet. 2010;6(10):e1001181.","journal-title":"PLoS Genet"},{"issue":"12","key":"361_CR22","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1212\/WNL.0000000000000797","volume":"83","author":"JC Deenen","year":"2014","unstructured":"Deenen JC, et al. Population-based incidence and prevalence of facioscapulohumeral dystrophy. Neurology. 2014;83(12):1056\u20139.","journal-title":"Neurology"},{"issue":"16","key":"361_CR23","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1093\/hmg\/ddaa164","volume":"29","author":"CRS Banerji","year":"2020","unstructured":"Banerji CRS, et al. Skeletal muscle regeneration in facioscapulohumeral muscular dystrophy is correlated with pathological severity. Hum Mol Genet. 2020;29(16):2746\u201360.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"361_CR24","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/nbm.1494","volume":"23","author":"HE Kan","year":"2010","unstructured":"Kan HE, et al. Only fat infiltrated muscles in resting lower leg of FSHD patients show disturbed energy metabolism. NMR Biomed. 2010;23(6):563\u20138.","journal-title":"NMR Biomed"},{"key":"361_CR25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.molimm.2021.05.009","volume":"136","author":"MLM Jongsma","year":"2021","unstructured":"Jongsma MLM, Neefjes J, Spaapen RM. Playing hide and seek: Tumor cells in control of MHC class I antigen presentation. Mol Immunol. 2021;136:36\u201344.","journal-title":"Mol Immunol"},{"issue":"5","key":"361_CR26","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.devcel.2019.06.011","volume":"50","author":"GL Chew","year":"2019","unstructured":"Chew GL, et al. DUX4 Suppresses MHC Class I to Promote Cancer Immune Evasion and Resistance to Checkpoint Blockade. Dev Cell. 2019;50(5):658-671 e7.","journal-title":"Dev Cell"},{"issue":"16","key":"361_CR27","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1089\/ars.2014.6090","volume":"22","author":"CL Himeda","year":"2015","unstructured":"Himeda CL, Jones TI, Jones PL. Facioscapulohumeral muscular dystrophy as a model for epigenetic regulation and disease. Antioxid Redox Signal. 2015;22(16):1463\u201382.","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"361_CR28","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1124\/jpet.119.259663","volume":"370","author":"J Oliva","year":"2019","unstructured":"Oliva J, et al. Clinically Advanced p38 Inhibitors Suppress DUX4 Expression in Cellular and Animal Models of Facioscapulohumeral Muscular Dystrophy. J Pharmacol Exp Ther. 2019;370(2):219\u201330.","journal-title":"J Pharmacol Exp Ther"},{"issue":"46","key":"361_CR29","doi-asserted-by":"publisher","first-page":"18157","DOI":"10.1073\/pnas.0708659104","volume":"104","author":"M Dixit","year":"2007","unstructured":"Dixit M, et al. DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1. Proc Natl Acad Sci U S A. 2007;104(46):18157\u201362.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"361_CR30","doi-asserted-by":"publisher","first-page":"e1000394","DOI":"10.1371\/journal.pgen.1000394","volume":"5","author":"A Ottaviani","year":"2009","unstructured":"Ottaviani A, et al. The D4Z4 macrosatellite repeat acts as a CTCF and A-type lamins-dependent insulator in facio-scapulo-humeral dystrophy. PLoS Genet. 2009;5(2):e1000394.","journal-title":"PLoS Genet"},{"key":"361_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1741-7007-7-41","volume":"7","author":"B Bodega","year":"2009","unstructured":"Bodega B, et al. Remodeling of the chromatin structure of the facioscapulohumeral muscular dystrophy (FSHD) locus and upregulation of FSHD-related gene 1 (FRG1) expression during human myogenic differentiation. BMC Biol. 2009;7:41.","journal-title":"BMC Biol"},{"issue":"4","key":"361_CR32","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.cell.2012.03.035","volume":"149","author":"DS Cabianca","year":"2012","unstructured":"Cabianca DS, et al. A long ncRNA links copy number variation to a polycomb\/trithorax epigenetic switch in FSHD muscular dystrophy. Cell. 2012;149(4):819\u201331.","journal-title":"Cell"},{"issue":"7","key":"361_CR33","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1016\/j.ymthe.2018.04.019","volume":"26","author":"CL Himeda","year":"2018","unstructured":"Himeda CL, et al. Identification of Epigenetic Regulators of DUX4-fl for Targeted Therapy of Facioscapulohumeral Muscular Dystrophy. Mol Ther. 2018;26(7):1797\u2013807.","journal-title":"Mol Ther"},{"issue":"8","key":"361_CR34","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/s41588-021-00893-0","volume":"53","author":"EJ Grow","year":"2021","unstructured":"Grow EJ, et al. p53 convergently activates Dux\/DUX4 in embryonic stem cells and in facioscapulohumeral muscular dystrophy cell models. Nat Genet. 2021;53(8):1207\u201320.","journal-title":"Nat Genet"},{"issue":"10","key":"361_CR35","doi-asserted-by":"publisher","first-page":"5144","DOI":"10.1093\/nar\/gkad230","volume":"51","author":"E Mocciaro","year":"2023","unstructured":"Mocciaro E, et al. WDR5 is required for DUX4 expression and its pathological effects in FSHD muscular dystrophy. Nucleic Acids Res. 2023;51(10):5144\u201361.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"361_CR36","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1002\/humu.22593","volume":"35","author":"W Zeng","year":"2014","unstructured":"Zeng W, et al. Genetic and epigenetic characteristics of FSHD-associated 4q and 10q D4Z4 that are distinct from non-4q\/10q D4Z4 homologs. Hum Mutat. 2014;35(8):998\u20131010.","journal-title":"Hum Mutat"},{"issue":"5","key":"361_CR37","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.ajhg.2016.03.013","volume":"98","author":"ML van den Boogaard","year":"2016","unstructured":"van den Boogaard ML, et al. Mutations in DNMT3B Modify Epigenetic Repression of the D4Z4 Repeat and the Penetrance of Facioscapulohumeral Dystrophy. Am J Hum Genet. 2016;98(5):1020\u20139.","journal-title":"Am J Hum Genet"},{"key":"361_CR38","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.semcdb.2020.03.003","volume":"104","author":"P Maire","year":"2020","unstructured":"Maire P, et al. Myogenesis control by SIX transcriptional complexes. Semin Cell Dev Biol. 2020;104:51\u201364.","journal-title":"Semin Cell Dev Biol"},{"key":"361_CR39","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ydbio.2020.10.005","volume":"469","author":"C Viaut","year":"2021","unstructured":"Viaut C, Weldon S, Munsterberg A. Fine-tuning of the PAX-SIX-EYA-DACH network by multiple microRNAs controls embryo myogenesis. Dev Biol. 2021;469:68\u201379.","journal-title":"Dev Biol"},{"issue":"4","key":"361_CR40","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00018-008-8335-4","volume":"66","author":"JP Kumar","year":"2009","unstructured":"Kumar JP. The sine oculis homeobox (SIX) family of transcription factors as regulators of development and disease. Cell Mol Life Sci. 2009;66(4):565\u201383.","journal-title":"Cell Mol Life Sci"},{"issue":"7","key":"361_CR41","doi-asserted-by":"publisher","first-page":"eabq7744","DOI":"10.1126\/sciadv.abq7744","volume":"9","author":"K Inoue","year":"2023","unstructured":"Inoue K, et al. DUX4 double whammy: The transcription factor that causes a rare muscular dystrophy also kills the precursors of the human nose. Sci Adv. 2023;9(7):eabq7744.","journal-title":"Sci Adv"},{"issue":"17","key":"361_CR42","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.1016\/j.yexcr.2010.08.001","volume":"316","author":"H Yajima","year":"2010","unstructured":"Yajima H, et al. Six family genes control the proliferation and differentiation of muscle satellite cells. Exp Cell Res. 2010;316(17):2932\u201344.","journal-title":"Exp Cell Res"},{"issue":"1\u20132","key":"361_CR43","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0925-4773(99)00045-3","volume":"83","author":"HC Seo","year":"1999","unstructured":"Seo HC, et al. Six class homeobox genes in drosophila belong to three distinct families and are involved in head development. Mech Dev. 1999;83(1\u20132):127\u201339.","journal-title":"Mech Dev"},{"issue":"6","key":"361_CR44","doi-asserted-by":"publisher","first-page":"e1010781","DOI":"10.1371\/journal.pgen.1010781","volume":"19","author":"M Wurmser","year":"2023","unstructured":"Wurmser M, et al. Overlapping functions of SIX homeoproteins during embryonic myogenesis. PLoS Genet. 2023;19(6):e1010781.","journal-title":"PLoS Genet"},{"issue":"5","key":"361_CR45","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1083\/jcb.201201050","volume":"198","author":"F Le Grand","year":"2012","unstructured":"Le Grand F, et al. Six1 regulates stem cell repair potential and self-renewal during skeletal muscle regeneration. J Cell Biol. 2012;198(5):815\u201332.","journal-title":"J Cell Biol"},{"key":"361_CR46","doi-asserted-by":"publisher","first-page":"707854","DOI":"10.3389\/fcell.2021.707854","volume":"9","author":"L Meurer","year":"2021","unstructured":"Meurer L, et al. The SIX Family of Transcription Factors: Common Themes Integrating Developmental and Cancer Biology. Front Cell Dev Biol. 2021;9:707854.","journal-title":"Front Cell Dev Biol"},{"issue":"21","key":"361_CR47","doi-asserted-by":"publisher","first-page":"8090","DOI":"10.1073\/pnas.0308475101","volume":"101","author":"RG Ruf","year":"2004","unstructured":"Ruf RG, et al. SIX1 mutations cause branchio-oto-renal syndrome by disruption of EYA1-SIX1-DNA complexes. Proc Natl Acad Sci U S A. 2004;101(21):8090\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"361_CR48","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1002\/ijc.28755","volume":"136","author":"W Wu","year":"2015","unstructured":"Wu W, et al. Six1: a critical transcription factor in tumorigenesis. Int J Cancer. 2015;136(6):1245\u201353.","journal-title":"Int J Cancer"},{"issue":"2","key":"361_CR49","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.bbadis.2006.05.009","volume":"1772","author":"SM van der Maarel","year":"2007","unstructured":"van der Maarel SM, Frants RR, Padberg GW. Facioscapulohumeral muscular dystrophy. Biochim Biophys Acta. 2007;1772(2):186\u201394.","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"361_CR50","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.molmed.2011.01.001","volume":"17","author":"SM van der Maarel","year":"2011","unstructured":"van der Maarel SM, Tawil R, Tapscott SJ. Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence. Trends Mol Med. 2011;17(5):252\u20138.","journal-title":"Trends Mol Med"},{"issue":"1","key":"361_CR51","doi-asserted-by":"publisher","first-page":"16957","DOI":"10.1038\/s41598-018-35150-8","volume":"8","author":"D Bosnakovski","year":"2018","unstructured":"Bosnakovski D, et al. Low level DUX4 expression disrupts myogenesis through deregulation of myogenic gene expression. Sci Rep. 2018;8(1):16957.","journal-title":"Sci Rep"},{"issue":"2","key":"361_CR52","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1517\/14728222.2014.978860","volume":"19","author":"MA Blevins","year":"2015","unstructured":"Blevins MA, et al. The SIX1-EYA transcriptional complex as a therapeutic target in cancer. Expert Opin Ther Targets. 2015;19(2):213\u201325.","journal-title":"Expert Opin Ther Targets"},{"key":"361_CR53","doi-asserted-by":"crossref","unstructured":"Cowley MV, et al. An in silico FSHD muscle fiber for modeling DUX4 dynamics and predicting the impact of therapy. Elife. 2023;12:e88345.","DOI":"10.7554\/eLife.88345"},{"issue":"1","key":"361_CR54","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1582-4934.2012.01647.x","volume":"17","author":"A Tassin","year":"2013","unstructured":"Tassin A, et al. DUX4 expression in FSHD muscle cells: how could such a rare protein cause a myopathy? J Cell Mol Med. 2013;17(1):76\u201389.","journal-title":"J Cell Mol Med"},{"issue":"20","key":"361_CR55","doi-asserted-by":"publisher","first-page":"5901","DOI":"10.1093\/hmg\/ddv315","volume":"24","author":"AM Rickard","year":"2015","unstructured":"Rickard AM, Petek LM, Miller DG. Endogenous DUX4 expression in FSHD myotubes is sufficient to cause cell death and disrupts RNA splicing and cell migration pathways. Hum Mol Genet. 2015;24(20):5901\u201314.","journal-title":"Hum Mol Genet"},{"key":"361_CR56","doi-asserted-by":"crossref","unstructured":"Gu Y, et al. Zeb1 Is a Potential Regulator of Six2 in the Proliferation, Apoptosis and Migration of Metanephric Mesenchyme Cells. Int J Mol Sci. 2016;17(8):1283.","DOI":"10.3390\/ijms17081283"},{"issue":"3","key":"361_CR57","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.ccell.2018.01.010","volume":"33","author":"L Li","year":"2018","unstructured":"Li L, et al. Transcriptional Regulation of the Warburg Effect in Cancer by SIX1. Cancer Cell. 2018;33(3):368-385 e7.","journal-title":"Cancer Cell"},{"key":"361_CR58","doi-asserted-by":"publisher","first-page":"725319","DOI":"10.3389\/fmolb.2021.725319","volume":"8","author":"Y Jin","year":"2021","unstructured":"Jin Y, et al. SIX1 Activation Is Involved in Cell Proliferation, Migration, and Anti-inflammation of Acute Ischemia\/Reperfusion Injury in Mice. Front Mol Biosci. 2021;8:725319.","journal-title":"Front Mol Biosci"},{"issue":"4","key":"361_CR59","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/wdev.230","volume":"5","author":"J Talbot","year":"2016","unstructured":"Talbot J, Maves L. Skeletal muscle fiber type: using insights from muscle developmental biology to dissect targets for susceptibility and resistance to muscle disease. Wiley Interdiscip Rev Dev Biol. 2016;5(4):518\u201334.","journal-title":"Wiley Interdiscip Rev Dev Biol"},{"issue":"20","key":"361_CR60","doi-asserted-by":"publisher","first-page":"5342","DOI":"10.1093\/hmg\/ddu251","volume":"23","author":"Z Yao","year":"2014","unstructured":"Yao Z, et al. DUX4-induced gene expression is the major molecular signature in FSHD skeletal muscle. Hum Mol Genet. 2014;23(20):5342\u201352.","journal-title":"Hum Mol Genet"},{"issue":"20","key":"361_CR61","first-page":"4419","volume":"25","author":"S Jagannathan","year":"2016","unstructured":"Jagannathan S, et al. Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells. Hum Mol Genet. 2016;25(20):4419\u201331.","journal-title":"Hum Mol Genet"},{"key":"361_CR62","doi-asserted-by":"crossref","unstructured":"Pineda JMB, Bradley RK. DUX4 is a common driver of immune evasion and immunotherapy failure in metastatic cancers. Elife. 2024;12:RP89017.","DOI":"10.7554\/eLife.89017.3"},{"issue":"6","key":"361_CR63","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.molmed.2021.03.008","volume":"27","author":"A Karpukhina","year":"2021","unstructured":"Karpukhina A, et al. Control of DUX4 Expression in Facioscapulohumeral Muscular Dystrophy and Cancer. Trends Mol Med. 2021;27(6):588\u2013601.","journal-title":"Trends Mol Med"},{"key":"361_CR64","doi-asserted-by":"crossref","unstructured":"Sidlauskaite E, et al. DUX4 Expression in FSHD Muscles: Focus on Its mRNA Regulation. J Pers Med. 2020;10(3).","DOI":"10.3390\/jpm10030073"},{"issue":"2","key":"361_CR65","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41582-022-00762-2","volume":"19","author":"MS Tihaya","year":"2023","unstructured":"Tihaya MS, et al. Facioscapulohumeral muscular dystrophy: the road to targeted therapies. Nat Rev Neurol. 2023;19(2):91\u2013108.","journal-title":"Nat Rev Neurol"},{"issue":"23","key":"361_CR66","doi-asserted-by":"publisher","first-page":"4661","DOI":"10.1093\/hmg\/ddt314","volume":"22","author":"GJ Block","year":"2013","unstructured":"Block GJ, et al. Wnt\/beta-catenin signaling suppresses DUX4 expression and prevents apoptosis of FSHD muscle cells. Hum Mol Genet. 2013;22(23):4661\u201372.","journal-title":"Hum Mol Genet"},{"issue":"11","key":"361_CR67","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1128\/MCB.00149-14","volume":"34","author":"CL Himeda","year":"2014","unstructured":"Himeda CL, et al. Myogenic enhancers regulate expression of the facioscapulohumeral muscular dystrophy-associated DUX4 gene. Mol Cell Biol. 2014;34(11):1942\u201355.","journal-title":"Mol Cell Biol"},{"issue":"3","key":"361_CR68","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1124\/jpet.119.264689","volume":"374","author":"LA Rojas","year":"2020","unstructured":"Rojas LA, et al. p38alpha Regulates Expression of DUX4 in a Model of Facioscapulohumeral Muscular Dystrophy. J Pharmacol Exp Ther. 2020;374(3):489\u201398.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"361_CR69","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13395-017-0134-x","volume":"7","author":"AE Campbell","year":"2017","unstructured":"Campbell AE, et al. BET bromodomain inhibitors and agonists of the beta-2 adrenergic receptor identified in screens for compounds that inhibit DUX4 expression in FSHD muscle cells. Skelet Muscle. 2017;7(1):16.","journal-title":"Skelet Muscle"},{"issue":"30","key":"361_CR70","doi-asserted-by":"publisher","first-page":"11837","DOI":"10.1074\/jbc.RA118.002633","volume":"293","author":"JM Cruz","year":"2018","unstructured":"Cruz JM, et al. Protein kinase A activation inhibits DUX4 gene expression in myotubes from patients with facioscapulohumeral muscular dystrophy. J Biol Chem. 2018;293(30):11837\u201349.","journal-title":"J Biol Chem"},{"key":"361_CR71","unstructured":"De Maeyer JGM, Monecke S, Hirsch R, Leng Loke P, Casein kinase 1 inhibitors for use in the treatment of diseases related to dux4 expression such as muscular dystrophy and cancer, USPTO. 2022, Facio Intellectual Property B.V. US-20190175596-A1."},{"key":"361_CR72","volume-title":"Inhibitors of DUX4 induction for regulation of muscle function","author":"ASU Rickard","year":"2023","unstructured":"Rickard ASU, Kiselyov A. Inhibitors of DUX4 induction for regulation of muscle function. US: Sonic Master Limited; 2023."},{"key":"361_CR73","doi-asserted-by":"crossref","unstructured":"Zetser A, Gredinger E, Bengal E. p38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation. Participation of the Mef2c transcription factor. J Biol Chem. 1999;274(8):5193\u2013200.","DOI":"10.1074\/jbc.274.8.5193"},{"key":"361_CR74","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13395-016-0074-x","volume":"6","author":"J Segales","year":"2016","unstructured":"Segales J, et al. Chromatin-wide and transcriptome profiling integration uncovers p38alpha MAPK as a global regulator of skeletal muscle differentiation. Skelet Muscle. 2016;6:9.","journal-title":"Skelet Muscle"},{"key":"361_CR75","doi-asserted-by":"publisher","first-page":"111030","DOI":"10.1016\/j.cellsig.2023.111030","volume":"115","author":"A Rafiq","year":"2024","unstructured":"Rafiq A, et al. GSK3beta phosphorylates Six1 transcription factor and regulates its APC\/C(Cdh1) mediated proteosomal degradation. Cell Signal. 2024;115:111030.","journal-title":"Cell Signal"},{"issue":"Pt B","key":"361_CR76","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.ijbiomac.2021.10.133","volume":"193","author":"A Rafiq","year":"2021","unstructured":"Rafiq A, et al. SIX1 transcription factor: A review of cellular functions and regulatory dynamics. Int J Biol Macromol. 2021;193(Pt B):1151\u201364.","journal-title":"Int J Biol Macromol"},{"key":"361_CR77","doi-asserted-by":"crossref","unstructured":"Zhang CT, et al. Dephosphorylation of Six2Y129 protects tyrosine hydroxylase-positive cells in SNpc by regulating TEA domain 1 expression. iScience. 2023;26(7):107049.","DOI":"10.1016\/j.isci.2023.107049"},{"issue":"3","key":"361_CR78","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s12031-019-01416-7","volume":"70","author":"J Gao","year":"2020","unstructured":"Gao J, et al. DA Immortalized Neuroblastoma Cells Self-protect Against Early Injury by Overexpressing Glial Cell-derived Neurotrophic Factor via Akt1\/Eya1\/Six2 Signaling. J Mol Neurosci. 2020;70(3):328\u201339.","journal-title":"J Mol Neurosci"},{"issue":"14","key":"361_CR79","doi-asserted-by":"publisher","first-page":"6253","DOI":"10.1128\/MCB.24.14.6253-6267.2004","volume":"24","author":"R Grifone","year":"2004","unstructured":"Grifone R, et al. Six1 and Eya1 expression can reprogram adult muscle from the slow-twitch phenotype into the fast-twitch phenotype. Mol Cell Biol. 2004;24(14):6253\u201367.","journal-title":"Mol Cell Biol"},{"issue":"3","key":"361_CR80","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1042\/BST20201302","volume":"49","author":"UK Soni","year":"2021","unstructured":"Soni UK, Roychoudhury K, Hegde RS. The Eyes Absent proteins in development and in developmental disorders. Biochem Soc Trans. 2021;49(3):1397\u2013408.","journal-title":"Biochem Soc Trans"},{"issue":"11","key":"361_CR81","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1242\/dev.071670","volume":"139","author":"M Ahmed","year":"2012","unstructured":"Ahmed M, Xu J, Xu PX. EYA1 and SIX1 drive the neuronal developmental program in cooperation with the SWI\/SNF chromatin-remodeling complex and SOX2 in the mammalian inner ear. Development. 2012;139(11):1965\u201377.","journal-title":"Development"},{"issue":"7","key":"361_CR82","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/ng1378","volume":"36","author":"C Simone","year":"2004","unstructured":"Simone C, et al. p38 pathway targets SWI-SNF chromatin-remodeling complex to muscle-specific loci. Nat Genet. 2004;36(7):738\u201343.","journal-title":"Nat Genet"},{"issue":"1","key":"361_CR83","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S1534-5807(01)00011-9","volume":"1","author":"FC Hsiao","year":"2001","unstructured":"Hsiao FC, et al. Eyes absent mediates cross-talk between retinal determination genes and the receptor tyrosine kinase signaling pathway. Dev Cell. 2001;1(1):51\u201361.","journal-title":"Dev Cell"},{"key":"361_CR84","doi-asserted-by":"publisher","first-page":"136088","DOI":"10.1016\/j.neulet.2021.136088","volume":"760","author":"J Gao","year":"2021","unstructured":"Gao J, et al. Smarcd1 antagonizes the apoptosis of injured MES235 DA cells by enhancing the effect of Six2 on GDNF expression. Neurosci Lett. 2021;760:136088.","journal-title":"Neurosci Lett"},{"issue":"5","key":"361_CR85","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1128\/MCB.24.5.2132-2143.2004","volume":"24","author":"CL Himeda","year":"2004","unstructured":"Himeda CL, et al. Quantitative proteomic identification of six4 as the trex-binding factor in the muscle creatine kinase enhancer. Mol Cell Biol. 2004;24(5):2132\u201343.","journal-title":"Mol Cell Biol"},{"issue":"2","key":"361_CR86","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ydbio.2009.11.031","volume":"338","author":"C Niro","year":"2010","unstructured":"Niro C, et al. Six1 and Six4 gene expression is necessary to activate the fast-type muscle gene program in the mouse primary myotome. Dev Biol. 2010;338(2):168\u201382.","journal-title":"Dev Biol"},{"issue":"1","key":"361_CR87","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13395-016-0102-x","volume":"6","author":"I Sakakibara","year":"2016","unstructured":"Sakakibara I, et al. Six1 homeoprotein drives myofiber type IIA specialization in soleus muscle. Skelet Muscle. 2016;6(1):30.","journal-title":"Skelet Muscle"},{"issue":"19","key":"361_CR88","doi-asserted-by":"publisher","first-page":"5303","DOI":"10.1002\/pmic.200600056","volume":"6","author":"B Celegato","year":"2006","unstructured":"Celegato B, et al. Parallel protein and transcript profiles of FSHD patient muscles correlate to the D4Z4 arrangement and reveal a common impairment of slow to fast fibre differentiation and a general deregulation of MyoD-dependent genes. Proteomics. 2006;6(19):5303\u201321.","journal-title":"Proteomics"},{"issue":"8","key":"361_CR89","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1212\/WNL.0b013e318282513b","volume":"80","author":"S Lassche","year":"2013","unstructured":"Lassche S, et al. Sarcomeric dysfunction contributes to muscle weakness in facioscapulohumeral muscular dystrophy. Neurology. 2013;80(8):733\u20137.","journal-title":"Neurology"},{"issue":"5","key":"361_CR90","doi-asserted-by":"publisher","first-page":"166367","DOI":"10.1016\/j.bbadis.2022.166367","volume":"1868","author":"S Jagannathan","year":"2022","unstructured":"Jagannathan S. The evolution of DUX4 gene regulation and its implication for facioscapulohumeral muscular dystrophy. Biochim Biophys Acta Mol Basis Dis. 2022;1868(5):166367.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"6","key":"361_CR91","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/ng.3844","volume":"49","author":"PG Hendrickson","year":"2017","unstructured":"Hendrickson PG, et al. Conserved roles of mouse DUX and human DUX4 in activating cleavage-stage genes and MERVL\/HERVL retrotransposons. Nat Genet. 2017;49(6):925\u201334.","journal-title":"Nat Genet"},{"issue":"2","key":"361_CR92","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ydbio.2016.12.005","volume":"421","author":"TL Davis","year":"2017","unstructured":"Davis TL, Rebay I. Master regulators in development: Views from the Drosophila retinal determination and mammalian pluripotency gene networks. Dev Biol. 2017;421(2):93\u2013107.","journal-title":"Dev Biol"},{"key":"361_CR93","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/bs.ctdb.2014.11.009","volume":"111","author":"SA Moody","year":"2015","unstructured":"Moody SA, LaMantia AS. Transcriptional regulation of cranial sensory placode development. Curr Top Dev Biol. 2015;111:301\u201350.","journal-title":"Curr Top Dev Biol"},{"key":"361_CR94","doi-asserted-by":"crossref","unstructured":"Park BY, JP. Saint-Jeannet. Induction and Segregation of the Vertebrate Cranial Placodes. San Rafael: Morgan & Claypool Life Sciences; 2010.","DOI":"10.4199\/C00014ED1V01Y201007DEB003"},{"issue":"2","key":"361_CR95","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/ng.3765","volume":"49","author":"CT Gordon","year":"2017","unstructured":"Gordon CT, et al. De novo mutations in SMCHD1 cause Bosma arhinia microphthalmia syndrome and abrogate nasal development. Nat Genet. 2017;49(2):249\u201355.","journal-title":"Nat Genet"},{"issue":"2","key":"361_CR96","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/ng.3743","volume":"49","author":"ND Shaw","year":"2017","unstructured":"Shaw ND, et al. SMCHD1 mutations associated with a rare muscular dystrophy can also cause isolated arhinia and Bosma arhinia microphthalmia syndrome. Nat Genet. 2017;49(2):238\u201348.","journal-title":"Nat Genet"}],"container-title":["Skeletal Muscle"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13395-024-00361-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13395-024-00361-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13395-024-00361-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T12:04:43Z","timestamp":1733227483000},"score":1,"resource":{"primary":{"URL":"https:\/\/skeletalmusclejournal.biomedcentral.com\/articles\/10.1186\/s13395-024-00361-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,3]]},"references-count":96,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["361"],"URL":"https:\/\/doi.org\/10.1186\/s13395-024-00361-3","relation":{},"ISSN":["2044-5040"],"issn-type":[{"value":"2044-5040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,3]]},"assertion":[{"value":"2 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}